← Leaderboards
Radhakrishnan Padmanabhan
University Of Kansas Medical Center
$4,290,749
Attributed
$4,290,749
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $744.4K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,290,749 · 6
By mechanism
R01$2,134,103 · 2
U01$1,188,851 · 1
R21$817,795 · 2
R03$150,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Replicon”
- Jonathan Smith · Alphavax Human Vaccines, Inc.$20,943,892
- Charles M. Rice · Rockefeller University$17,960,348
- Richard J. Kuhn · Purdue University$15,751,691
- Jeffrey D Chulay · Alphavax Human Vaccines, Inc.$13,968,680
- Barton F Haynes · Duke University$10,283,290
- Robert E. Johnston · University Of North Carolina Chapel Hill$9,919,523
Research focus
RepliconDengue VirusEnzyme ActivityWest Nile VirusAntiviral AgentsDockingHigh Throughput ScreeningPeptide HydrolasesLibrariesLaboratoriesCulicidaeCytotoxicityMortality Vital StatisticsBaseInhibitor/AntagonistBiochemicalBinding (Molecular Function)Hepatitis C VirusCellsHelicaseEnzymesLeadIn VitroNational Institute Of Allergy And Infectious Disease
Grant awards (16)
Development of West Nile Virus/Broad Spectrum Flavivirus Protease Inhibitors$221,625
R21 · FY2015 · AI · contact PI
Development of West Nile Virus/Broad Spectrum Flavivirus Protease Inhibitors$199,570
R21 · FY2014 · AI · contact PI
Development of Antiviral Therapeutics for Dengue: Inhibitors of Viral Protease$543,312
U01 · FY2010 · AI · contact PI
Development of Antiviral Therapeutics for Dengue: Inhibitors of Viral Protease$645,539
U01 · FY2009 · AI · contact PI
Identification and Analysis of Flavivirus Protease and RNA Helicase Inhibitors$98,811
R01 · FY2009 · AI · contact PI
Identification and Analysis of Flavivirus Protease and RNA Helicase Inhibitors$332,631
R01 · FY2008 · AI · contact PI
Identification and Analysis of Flavivirus Protease and RNA Helicase Inhibitors$339,073
R01 · FY2007 · AI · contact PI
Identification and Analysis of Flavivirus Protease and RNA Helicase Inhibitors$332,806
R01 · FY2006 · AI · contact PI
Dengue and West Nile Viral Protease Inhibitors$191,400
R21 · FY2005 · AI
Dengue and West Nile Viral Protease Inhibitors$205,200
R21 · FY2004 · AI
FUNCTIONAL ANALYSIS OF DENGUE VIRUS ANTIGENS NS3 AND NS5$272,882
R01 · FY2003 · AI
FUNCTIONAL ANALYSIS OF DENGUE VIRUS ANTIGENS NS3 AND NS5$263,164
R01 · FY2002 · AI
FUNCTIONAL ANALYSIS OF DENGUE VIRUS ANTIGENS NS3 AND NS5$249,087
R01 · FY2001 · AI
VIRUS/HOST INTERACTIONS MODULATED BY HEPATITIC C VIRUS$75,000
R03 · FY2001 · AI
FUNCTIONAL ANALYSIS OF DENGUE VIRUS ANTIGENS NS3 AND NS5$245,649
R01 · FY2000 · AI
VIRUS/HOST INTERACTIONS MODULATED BY HEPATITIC C VIRUS$75,000
R03 · FY2000 · AI